MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand ...
MILFORD, Mass., Oct. 10, 2024 /PRNewswire/ -- Waters Corporation (WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence ...
Waters Corp.WAT recently announced that its indigenously built ACQUITY UPLC I-Class IVD/Xevo TQ-S micro IVD System has been classified as a U.S. FDA Class I medical device. Moreover, it has secured ...
Waters Corporation WAT has been continuously making new enhancements to gain momentum in the Liquid Chromatography Mass Spectrometry (LC-MS) market. This is evident from the fact that the company ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced that the Waters ® ACQUITY UPLC ® I-Class IVD/Xevo ® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I ...
Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs ...
Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results